img

Global Cell-Free Fetal DNA Testing Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Cell-Free Fetal DNA Testing Market Insights, Forecast to 2034

Cell-free DNA screening is a test that can determine if a woman has a higher chance of having a fetus with Down syndrome (trisomy 21), trisomy 18, trisomy 13 or an abnormality in the sex chromosomes (X and Y chromosomes). With this test, a sample of the woman's blood is taken after 10 weeks of pregnancy.
Market Analysis and InsightsGlobal Cell-Free Fetal DNA Testing Market
Global Cell-Free Fetal DNA Testing market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Cell-Free Fetal DNA Testing industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Cell-Free Fetal DNA Testing key companies include Roche, Arup Laboratories, PerkinElmer, Eurofins Biomnis, BGI, Berry Genomics, DAAN GENE, CapitalBio and Annoroad, etc. Roche, Arup Laboratories, PerkinElmer are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Cell-Free Fetal DNA Testing were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Cell-Free Fetal DNA Testing market and estimated to attract more attentions from industry insiders and investors.
Cell-Free Fetal DNA Testing can be divided into Abnormal Chromosome Number Detection, Gender Testing, Paternally Inherited Disorder Detection and Paternity Testing, etc. Abnormal Chromosome Number Detection is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Cell-Free Fetal DNA Testing is widely used in various fields, such as Hospital and Clinic Center, etc. Hospital provides greatest supports to the Cell-Free Fetal DNA Testing industry development. In 2022, global % revenue of Cell-Free Fetal DNA Testing went into Hospital filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Cell-Free Fetal DNA Testing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Cell-Free Fetal DNA Testing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Roche
Arup Laboratories
PerkinElmer
Eurofins Biomnis
BGI
Berry Genomics
DAAN GENE
CapitalBio
Annoroad
ADICON
KingMed
Segment by Type
Abnormal Chromosome Number Detection
Gender Testing
Paternally Inherited Disorder Detection
Paternity Testing
Others

Segment by Application


Hospital
Clinic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Cell-Free Fetal DNA Testing introduction, etc. Cell-Free Fetal DNA Testing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Cell-Free Fetal DNA Testing
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Free Fetal DNA Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Abnormal Chromosome Number Detection
1.2.3 Gender Testing
1.2.4 Paternally Inherited Disorder Detection
1.2.5 Paternity Testing
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cell-Free Fetal DNA Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-Free Fetal DNA Testing Market Perspective (2018-2033)
2.2 Global Cell-Free Fetal DNA Testing Growth Trends by Region
2.2.1 Cell-Free Fetal DNA Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cell-Free Fetal DNA Testing Historic Market Size by Region (2018-2023)
2.2.3 Cell-Free Fetal DNA Testing Forecasted Market Size by Region (2024-2033)
2.3 Cell-Free Fetal DNA Testing Market Dynamics
2.3.1 Cell-Free Fetal DNA Testing Industry Trends
2.3.2 Cell-Free Fetal DNA Testing Market Drivers
2.3.3 Cell-Free Fetal DNA Testing Market Challenges
2.3.4 Cell-Free Fetal DNA Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cell-Free Fetal DNA Testing by Players
3.1.1 Global Cell-Free Fetal DNA Testing Revenue by Players (2018-2023)
3.1.2 Global Cell-Free Fetal DNA Testing Revenue Market Share by Players (2018-2023)
3.2 Global Cell-Free Fetal DNA Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cell-Free Fetal DNA Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Cell-Free Fetal DNA Testing Market Concentration Ratio
3.4.1 Global Cell-Free Fetal DNA Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Free Fetal DNA Testing Revenue in 2022
3.5 Global Key Players of Cell-Free Fetal DNA Testing Head office and Area Served
3.6 Global Key Players of Cell-Free Fetal DNA Testing, Product and Application
3.7 Global Key Players of Cell-Free Fetal DNA Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Free Fetal DNA Testing Breakdown Data by Type
4.1 Global Cell-Free Fetal DNA Testing Historic Market Size by Type (2018-2023)
4.2 Global Cell-Free Fetal DNA Testing Forecasted Market Size by Type (2024-2033)
5 Cell-Free Fetal DNA Testing Breakdown Data by Application
5.1 Global Cell-Free Fetal DNA Testing Historic Market Size by Application (2018-2023)
5.2 Global Cell-Free Fetal DNA Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cell-Free Fetal DNA Testing Market Size (2018-2033)
6.2 North America Cell-Free Fetal DNA Testing Market Size by Type
6.2.1 North America Cell-Free Fetal DNA Testing Market Size by Type (2018-2023)
6.2.2 North America Cell-Free Fetal DNA Testing Market Size by Type (2024-2033)
6.2.3 North America Cell-Free Fetal DNA Testing Market Share by Type (2018-2033)
6.3 North America Cell-Free Fetal DNA Testing Market Size by Application
6.3.1 North America Cell-Free Fetal DNA Testing Market Size by Application (2018-2023)
6.3.2 North America Cell-Free Fetal DNA Testing Market Size by Application (2024-2033)
6.3.3 North America Cell-Free Fetal DNA Testing Market Share by Application (2018-2033)
6.4 North America Cell-Free Fetal DNA Testing Market Size by Country
6.4.1 North America Cell-Free Fetal DNA Testing Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Cell-Free Fetal DNA Testing Market Size by Country (2018-2023)
6.4.3 North America Cell-Free Fetal DNA Testing Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Cell-Free Fetal DNA Testing Market Size (2018-2033)
7.2 Europe Cell-Free Fetal DNA Testing Market Size by Type
7.2.1 Europe Cell-Free Fetal DNA Testing Market Size by Type (2018-2023)
7.2.2 Europe Cell-Free Fetal DNA Testing Market Size by Type (2024-2033)
7.2.3 Europe Cell-Free Fetal DNA Testing Market Share by Type (2018-2033)
7.3 Europe Cell-Free Fetal DNA Testing Market Size by Application
7.3.1 Europe Cell-Free Fetal DNA Testing Market Size by Application (2018-2023)
7.3.2 Europe Cell-Free Fetal DNA Testing Market Size by Application (2024-2033)
7.3.3 Europe Cell-Free Fetal DNA Testing Market Share by Application (2018-2033)
7.4 Europe Cell-Free Fetal DNA Testing Market Size by Country
7.4.1 Europe Cell-Free Fetal DNA Testing Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Cell-Free Fetal DNA Testing Market Size by Country (2018-2023)
7.4.3 Europe Cell-Free Fetal DNA Testing Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cell-Free Fetal DNA Testing Market Size (2018-2033)
8.2 China Cell-Free Fetal DNA Testing Market Size by Type
8.2.1 China Cell-Free Fetal DNA Testing Market Size by Type (2018-2023)
8.2.2 China Cell-Free Fetal DNA Testing Market Size by Type (2024-2033)
8.2.3 China Cell-Free Fetal DNA Testing Market Share by Type (2018-2033)
8.3 China Cell-Free Fetal DNA Testing Market Size by Application
8.3.1 China Cell-Free Fetal DNA Testing Market Size by Application (2018-2023)
8.3.2 China Cell-Free Fetal DNA Testing Market Size by Application (2024-2033)
8.3.3 China Cell-Free Fetal DNA Testing Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Cell-Free Fetal DNA Testing Market Size (2018-2033)
9.2 Asia Cell-Free Fetal DNA Testing Market Size by Type
9.2.1 Asia Cell-Free Fetal DNA Testing Market Size by Type (2018-2023)
9.2.2 Asia Cell-Free Fetal DNA Testing Market Size by Type (2024-2033)
9.2.3 Asia Cell-Free Fetal DNA Testing Market Share by Type (2018-2033)
9.3 Asia Cell-Free Fetal DNA Testing Market Size by Application
9.3.1 Asia Cell-Free Fetal DNA Testing Market Size by Application (2018-2023)
9.3.2 Asia Cell-Free Fetal DNA Testing Market Size by Application (2024-2033)
9.3.3 Asia Cell-Free Fetal DNA Testing Market Share by Application (2018-2033)
9.4 Asia Cell-Free Fetal DNA Testing Market Size by Region
9.4.1 Asia Cell-Free Fetal DNA Testing Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Cell-Free Fetal DNA Testing Market Size by Region (2018-2023)
9.4.3 Asia Cell-Free Fetal DNA Testing Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Cell-Free Fetal DNA Testing Introduction
11.1.4 Roche Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.1.5 Roche Recent Developments
11.2 Arup Laboratories
11.2.1 Arup Laboratories Company Details
11.2.2 Arup Laboratories Business Overview
11.2.3 Arup Laboratories Cell-Free Fetal DNA Testing Introduction
11.2.4 Arup Laboratories Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.2.5 Arup Laboratories Recent Developments
11.3 PerkinElmer
11.3.1 PerkinElmer Company Details
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Cell-Free Fetal DNA Testing Introduction
11.3.4 PerkinElmer Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.3.5 PerkinElmer Recent Developments
11.4 Eurofins Biomnis
11.4.1 Eurofins Biomnis Company Details
11.4.2 Eurofins Biomnis Business Overview
11.4.3 Eurofins Biomnis Cell-Free Fetal DNA Testing Introduction
11.4.4 Eurofins Biomnis Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.4.5 Eurofins Biomnis Recent Developments
11.5 BGI
11.5.1 BGI Company Details
11.5.2 BGI Business Overview
11.5.3 BGI Cell-Free Fetal DNA Testing Introduction
11.5.4 BGI Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.5.5 BGI Recent Developments
11.6 Berry Genomics
11.6.1 Berry Genomics Company Details
11.6.2 Berry Genomics Business Overview
11.6.3 Berry Genomics Cell-Free Fetal DNA Testing Introduction
11.6.4 Berry Genomics Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.6.5 Berry Genomics Recent Developments
11.7 DAAN GENE
11.7.1 DAAN GENE Company Details
11.7.2 DAAN GENE Business Overview
11.7.3 DAAN GENE Cell-Free Fetal DNA Testing Introduction
11.7.4 DAAN GENE Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.7.5 DAAN GENE Recent Developments
11.8 CapitalBio
11.8.1 CapitalBio Company Details
11.8.2 CapitalBio Business Overview
11.8.3 CapitalBio Cell-Free Fetal DNA Testing Introduction
11.8.4 CapitalBio Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.8.5 CapitalBio Recent Developments
11.9 Annoroad
11.9.1 Annoroad Company Details
11.9.2 Annoroad Business Overview
11.9.3 Annoroad Cell-Free Fetal DNA Testing Introduction
11.9.4 Annoroad Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.9.5 Annoroad Recent Developments
11.10 ADICON
11.10.1 ADICON Company Details
11.10.2 ADICON Business Overview
11.10.3 ADICON Cell-Free Fetal DNA Testing Introduction
11.10.4 ADICON Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.10.5 ADICON Recent Developments
11.11 KingMed
11.11.1 KingMed Company Details
11.11.2 KingMed Business Overview
11.11.3 KingMed Cell-Free Fetal DNA Testing Introduction
11.11.4 KingMed Revenue in Cell-Free Fetal DNA Testing Business (2018-2023)
11.11.5 KingMed Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cell-Free Fetal DNA Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Abnormal Chromosome Number Detection
Table 3. Key Players of Gender Testing
Table 4. Key Players of Paternally Inherited Disorder Detection
Table 5. Key Players of Paternity Testing
Table 6. Key Players of Others
Table 7. Global Cell-Free Fetal DNA Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Cell-Free Fetal DNA Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Cell-Free Fetal DNA Testing Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Cell-Free Fetal DNA Testing Market Share by Region (2018-2023)
Table 11. Global Cell-Free Fetal DNA Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Cell-Free Fetal DNA Testing Market Share by Region (2024-2033)
Table 13. Cell-Free Fetal DNA Testing Market Trends
Table 14. Cell-Free Fetal DNA Testing Market Drivers
Table 15. Cell-Free Fetal DNA Testing Market Challenges
Table 16. Cell-Free Fetal DNA Testing Market Restraints
Table 17. Global Cell-Free Fetal DNA Testing Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Cell-Free Fetal DNA Testing Revenue Share by Players (2018-2023)
Table 19. Global Top Cell-Free Fetal DNA Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free Fetal DNA Testing as of 2022)
Table 20. Global Cell-Free Fetal DNA Testing Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Cell-Free Fetal DNA Testing Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Cell-Free Fetal DNA Testing, Headquarters and Area Served
Table 23. Global Key Players of Cell-Free Fetal DNA Testing, Product and Application
Table 24. Global Key Players of Cell-Free Fetal DNA Testing, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell-Free Fetal DNA Testing Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Cell-Free Fetal DNA Testing Revenue Market Share by Type (2018-2023)
Table 28. Global Cell-Free Fetal DNA Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Cell-Free Fetal DNA Testing Revenue Market Share by Type (2024-2033)
Table 30. Global Cell-Free Fetal DNA Testing Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Cell-Free Fetal DNA Testing Revenue Share by Application (2018-2023)
Table 32. Global Cell-Free Fetal DNA Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Cell-Free Fetal DNA Testing Revenue Share by Application (2024-2033)
Table 34. North America Cell-Free Fetal DNA Testing Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Cell-Free Fetal DNA Testing Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Cell-Free Fetal DNA Testing Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Cell-Free Fetal DNA Testing Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Cell-Free Fetal DNA Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Cell-Free Fetal DNA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Cell-Free Fetal DNA Testing Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Cell-Free Fetal DNA Testing Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Cell-Free Fetal DNA Testing Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Cell-Free Fetal DNA Testing Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Cell-Free Fetal DNA Testing Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Cell-Free Fetal DNA Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Cell-Free Fetal DNA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Cell-Free Fetal DNA Testing Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Cell-Free Fetal DNA Testing Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Cell-Free Fetal DNA Testing Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Cell-Free Fetal DNA Testing Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Cell-Free Fetal DNA Testing Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Cell-Free Fetal DNA Testing Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Cell-Free Fetal DNA Testing Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Cell-Free Fetal DNA Testing Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Cell-Free Fetal DNA Testing Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Cell-Free Fetal DNA Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Cell-Free Fetal DNA Testing Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Cell-Free Fetal DNA Testing Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size by Country (2024-2033) & (US$ Million)
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Cell-Free Fetal DNA Testing Product
Table 69. Roche Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 70. Roche Recent Developments
Table 71. Arup Laboratories Company Details
Table 72. Arup Laboratories Business Overview
Table 73. Arup Laboratories Cell-Free Fetal DNA Testing Product
Table 74. Arup Laboratories Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 75. Arup Laboratories Recent Developments
Table 76. PerkinElmer Company Details
Table 77. PerkinElmer Business Overview
Table 78. PerkinElmer Cell-Free Fetal DNA Testing Product
Table 79. PerkinElmer Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 80. PerkinElmer Recent Developments
Table 81. Eurofins Biomnis Company Details
Table 82. Eurofins Biomnis Business Overview
Table 83. Eurofins Biomnis Cell-Free Fetal DNA Testing Product
Table 84. Eurofins Biomnis Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 85. Eurofins Biomnis Recent Developments
Table 86. BGI Company Details
Table 87. BGI Business Overview
Table 88. BGI Cell-Free Fetal DNA Testing Product
Table 89. BGI Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 90. BGI Recent Developments
Table 91. Berry Genomics Company Details
Table 92. Berry Genomics Business Overview
Table 93. Berry Genomics Cell-Free Fetal DNA Testing Product
Table 94. Berry Genomics Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 95. Berry Genomics Recent Developments
Table 96. DAAN GENE Company Details
Table 97. DAAN GENE Business Overview
Table 98. DAAN GENE Cell-Free Fetal DNA Testing Product
Table 99. DAAN GENE Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 100. DAAN GENE Recent Developments
Table 101. CapitalBio Company Details
Table 102. CapitalBio Business Overview
Table 103. CapitalBio Cell-Free Fetal DNA Testing Product
Table 104. CapitalBio Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 105. CapitalBio Recent Developments
Table 106. Annoroad Company Details
Table 107. Annoroad Business Overview
Table 108. Annoroad Cell-Free Fetal DNA Testing Product
Table 109. Annoroad Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 110. Annoroad Recent Developments
Table 111. ADICON Company Details
Table 112. ADICON Business Overview
Table 113. ADICON Cell-Free Fetal DNA Testing Product
Table 114. ADICON Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 115. ADICON Recent Developments
Table 116. KingMed Company Details
Table 117. KingMed Business Overview
Table 118. KingMed Cell-Free Fetal DNA Testing Product
Table 119. KingMed Revenue in Cell-Free Fetal DNA Testing Business (2018-2023) & (US$ Million)
Table 120. KingMed Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell-Free Fetal DNA Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Cell-Free Fetal DNA Testing Market Share by Type: 2022 VS 2033
Figure 3. Abnormal Chromosome Number Detection Features
Figure 4. Gender Testing Features
Figure 5. Paternally Inherited Disorder Detection Features
Figure 6. Paternity Testing Features
Figure 7. Others Features
Figure 8. Global Cell-Free Fetal DNA Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Cell-Free Fetal DNA Testing Market Share by Application: 2022 VS 2033
Figure 10. Hospital Case Studies
Figure 11. Clinic Center Case Studies
Figure 12. Cell-Free Fetal DNA Testing Report Years Considered
Figure 13. Global Cell-Free Fetal DNA Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Cell-Free Fetal DNA Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Cell-Free Fetal DNA Testing Market Share by Region: 2022 VS 2033
Figure 16. Global Cell-Free Fetal DNA Testing Market Share by Players in 2022
Figure 17. Global Top Cell-Free Fetal DNA Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free Fetal DNA Testing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Cell-Free Fetal DNA Testing Revenue in 2022
Figure 19. North America Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Cell-Free Fetal DNA Testing Market Share by Type (2018-2033)
Figure 21. North America Cell-Free Fetal DNA Testing Market Share by Application (2018-2033)
Figure 22. North America Cell-Free Fetal DNA Testing Market Share by Country (2018-2033)
Figure 23. United States Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Cell-Free Fetal DNA Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Cell-Free Fetal DNA Testing Market Share by Type (2018-2033)
Figure 27. Europe Cell-Free Fetal DNA Testing Market Share by Application (2018-2033)
Figure 28. Europe Cell-Free Fetal DNA Testing Market Share by Country (2018-2033)
Figure 29. Germany Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Cell-Free Fetal DNA Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Cell-Free Fetal DNA Testing Market Share by Type (2018-2033)
Figure 37. China Cell-Free Fetal DNA Testing Market Share by Application (2018-2033)
Figure 38. Asia Cell-Free Fetal DNA Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Cell-Free Fetal DNA Testing Market Share by Type (2018-2033)
Figure 40. Asia Cell-Free Fetal DNA Testing Market Share by Application (2018-2033)
Figure 41. Asia Cell-Free Fetal DNA Testing Market Share by Region (2018-2033)
Figure 42. Japan Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Cell-Free Fetal DNA Testing Market Share by Country (2018-2033)
Figure 52. Brazil Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Cell-Free Fetal DNA Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Roche Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 59. Arup Laboratories Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 60. PerkinElmer Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 61. Eurofins Biomnis Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 62. BGI Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 63. Berry Genomics Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 64. DAAN GENE Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 65. CapitalBio Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 66. Annoroad Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 67. ADICON Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 68. KingMed Revenue Growth Rate in Cell-Free Fetal DNA Testing Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries